An introduction to the Marburg virus vaccine consortium, MARVAC.

Saved in:
Bibliographic Details
Title: An introduction to the Marburg virus vaccine consortium, MARVAC.
Authors: Cross RW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Longini IM; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America., Becker S; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany., Bok K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Boucher D; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America., Carroll MW; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom., Díaz JV; World Health Organization, Geneva, Switzerland., Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America., Draghia-Akli R; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America., Duworko JT; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia., Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Egan MA; Auro Vaccines, Pearl River, New York, United States of America., Fast P; IAVI, New York, New York, United States of America., Finan A; Sabin vaccine Institute, Washington, DC, United States of America., Finch C; Sabin vaccine Institute, Washington, DC, United States of America., Fleming TR; University of Washington, Seattle, Washington, United States of America., Fusco J; Public Health Vaccines, Cambridge, Massachusetts, United States of America., Geisbert TW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Griffiths A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Hensley LE; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America., Honko A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Hunegnaw R; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Jakubik J; Sabin vaccine Institute, Washington, DC, United States of America., Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Luhn K; Janssen Vaccines & Prevention, Leiden, the Netherlands., Matassov D; Auro Vaccines, Pearl River, New York, United States of America., Meshulam J; Auro Vaccines, Pearl River, New York, United States of America., Nelson EV; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Parks CL; IAVI, New York, New York, United States of America., Rustomjee R; Sabin vaccine Institute, Washington, DC, United States of America., Safronetz D; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Schwartz LM; World Health Organization, Geneva, Switzerland., Smith D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Smock P; Sabin vaccine Institute, Washington, DC, United States of America., Sow Y; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America., Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Warfield KL; Emergent BioSolutions, Gaithersburg, Maryland, United States of America., Wolfe D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Woolsey C; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Zahn R; Janssen Vaccines & Prevention, Leiden, the Netherlands., Henao-Restrepo AM; World Health Organization, Geneva, Switzerland., Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2022 Oct 13; Vol. 18 (10), pp. e1010805. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36227853
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An introduction to the Marburg virus vaccine consortium, MARVAC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cross+RW%22">Cross RW</searchLink>; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Longini+IM%22">Longini IM</searchLink>; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America.<br /><searchLink fieldCode="AU" term="%22Becker+S%22">Becker S</searchLink>; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bok+K%22">Bok K</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Boucher+D%22">Boucher D</searchLink>; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Carroll+MW%22">Carroll MW</searchLink>; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Díaz+JV%22">Díaz JV</searchLink>; World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Dowling+WE%22">Dowling WE</searchLink>; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Draghia-Akli+R%22">Draghia-Akli R</searchLink>; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22Duworko+JT%22">Duworko JT</searchLink>; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia.<br /><searchLink fieldCode="AU" term="%22Dye+JM%22">Dye JM</searchLink>; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Egan+MA%22">Egan MA</searchLink>; Auro Vaccines, Pearl River, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+P%22">Fast P</searchLink>; IAVI, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Finan+A%22">Finan A</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Finch+C%22">Finch C</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Fleming+TR%22">Fleming TR</searchLink>; University of Washington, Seattle, Washington, United States of America.<br /><searchLink fieldCode="AU" term="%22Fusco+J%22">Fusco J</searchLink>; Public Health Vaccines, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Geisbert+TW%22">Geisbert TW</searchLink>; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Griffiths+A%22">Griffiths A</searchLink>; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Günther+S%22">Günther S</searchLink>; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hensley+LE%22">Hensley LE</searchLink>; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Honko+A%22">Honko A</searchLink>; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Hunegnaw+R%22">Hunegnaw R</searchLink>; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Jakubik+J%22">Jakubik J</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Ledgerwood+J%22">Ledgerwood J</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Luhn+K%22">Luhn K</searchLink>; Janssen Vaccines & Prevention, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Matassov+D%22">Matassov D</searchLink>; Auro Vaccines, Pearl River, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Meshulam+J%22">Meshulam J</searchLink>; Auro Vaccines, Pearl River, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Nelson+EV%22">Nelson EV</searchLink>; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Parks+CL%22">Parks CL</searchLink>; IAVI, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Rustomjee+R%22">Rustomjee R</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Safronetz+D%22">Safronetz D</searchLink>; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Schwartz+LM%22">Schwartz LM</searchLink>; World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Smock+P%22">Smock P</searchLink>; Sabin vaccine Institute, Washington, DC, United States of America.<br /><searchLink fieldCode="AU" term="%22Sow+Y%22">Sow Y</searchLink>; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Spiropoulou+CF%22">Spiropoulou CF</searchLink>; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.<br /><searchLink fieldCode="AU" term="%22Sullivan+NJ%22">Sullivan NJ</searchLink>; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Warfield+KL%22">Warfield KL</searchLink>; Emergent BioSolutions, Gaithersburg, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Wolfe+D%22">Wolfe D</searchLink>; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Woolsey+C%22">Woolsey C</searchLink>; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Zahn+R%22">Zahn R</searchLink>; Janssen Vaccines & Prevention, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Henao-Restrepo+AM%22">Henao-Restrepo AM</searchLink>; World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Muñoz-Fontela+C%22">Muñoz-Fontela C</searchLink>; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Marzi+A%22">Marzi A</searchLink>; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2022 Oct 13; Vol. 18 (10), pp. e1010805. <i>Date of Electronic Publication: </i>2022 Oct 13 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36227853
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1010805
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1010805
    Titles:
      – TitleFull: An introduction to the Marburg virus vaccine consortium, MARVAC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cross RW
      – PersonEntity:
          Name:
            NameFull: Longini IM
      – PersonEntity:
          Name:
            NameFull: Becker S
      – PersonEntity:
          Name:
            NameFull: Bok K
      – PersonEntity:
          Name:
            NameFull: Boucher D
      – PersonEntity:
          Name:
            NameFull: Carroll MW
      – PersonEntity:
          Name:
            NameFull: Díaz JV
      – PersonEntity:
          Name:
            NameFull: Dowling WE
      – PersonEntity:
          Name:
            NameFull: Draghia-Akli R
      – PersonEntity:
          Name:
            NameFull: Duworko JT
      – PersonEntity:
          Name:
            NameFull: Dye JM
      – PersonEntity:
          Name:
            NameFull: Egan MA
      – PersonEntity:
          Name:
            NameFull: Fast P
      – PersonEntity:
          Name:
            NameFull: Finan A
      – PersonEntity:
          Name:
            NameFull: Finch C
      – PersonEntity:
          Name:
            NameFull: Fleming TR
      – PersonEntity:
          Name:
            NameFull: Fusco J
      – PersonEntity:
          Name:
            NameFull: Geisbert TW
      – PersonEntity:
          Name:
            NameFull: Griffiths A
      – PersonEntity:
          Name:
            NameFull: Günther S
      – PersonEntity:
          Name:
            NameFull: Hensley LE
      – PersonEntity:
          Name:
            NameFull: Honko A
      – PersonEntity:
          Name:
            NameFull: Hunegnaw R
      – PersonEntity:
          Name:
            NameFull: Jakubik J
      – PersonEntity:
          Name:
            NameFull: Ledgerwood J
      – PersonEntity:
          Name:
            NameFull: Luhn K
      – PersonEntity:
          Name:
            NameFull: Matassov D
      – PersonEntity:
          Name:
            NameFull: Meshulam J
      – PersonEntity:
          Name:
            NameFull: Nelson EV
      – PersonEntity:
          Name:
            NameFull: Parks CL
      – PersonEntity:
          Name:
            NameFull: Rustomjee R
      – PersonEntity:
          Name:
            NameFull: Safronetz D
      – PersonEntity:
          Name:
            NameFull: Schwartz LM
      – PersonEntity:
          Name:
            NameFull: Smith D
      – PersonEntity:
          Name:
            NameFull: Smock P
      – PersonEntity:
          Name:
            NameFull: Sow Y
      – PersonEntity:
          Name:
            NameFull: Spiropoulou CF
      – PersonEntity:
          Name:
            NameFull: Sullivan NJ
      – PersonEntity:
          Name:
            NameFull: Warfield KL
      – PersonEntity:
          Name:
            NameFull: Wolfe D
      – PersonEntity:
          Name:
            NameFull: Woolsey C
      – PersonEntity:
          Name:
            NameFull: Zahn R
      – PersonEntity:
          Name:
            NameFull: Henao-Restrepo AM
      – PersonEntity:
          Name:
            NameFull: Muñoz-Fontela C
      – PersonEntity:
          Name:
            NameFull: Marzi A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 10
              Text: 2022 Oct 13
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1